1 min to read News Posted on January 28, 2023 London-listed SPAC targets merger with chronic disease drug developer Istesso – Yahoo Eurosport UK London-listed SPAC targets merger with chronic disease drug developer Istesso Yahoo Eurosport UK Source: London-listed SPAC targets merger with chronic disease drug developer Istesso – Yahoo Eurosport UK share tweet share Report: SPACs and De-SPACing: Considerations for Going Public Through a Combination with a SPAC5 things you really should not buy in 2023 – MorningstarSPAC Promoters Lost $1B+ in 2022, and There’s More Pain to Come – 24/7 Wall St.By the Numbers: Four Practices Big Law Firms Need to Power 2023 – Bloomberg Law Tags: SPACs